These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3774720)

  • 1. Neuroleptic malignant syndrome successfully treated with amantidine.
    Woo J; Teoh R; Vallance-Owen J
    Postgrad Med J; 1986 Aug; 62(730):809-10. PubMed ID: 3774720
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine in the neuroleptic malignant syndrome.
    Gangadhar BN; Desai NG; Channabasavanna SM
    J Clin Psychiatry; 1984 Dec; 45(12):526. PubMed ID: 6501243
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
    Hermesh H; Sirota P; Eviatar J
    Biol Psychiatry; 1989 Apr; 25(7):962-5. PubMed ID: 2720007
    [No Abstract]   [Full Text] [Related]  

  • 4. Amantadine in neuroleptic malignant syndrome.
    Jee A
    Postgrad Med J; 1987 Jun; 63(740):508-9. PubMed ID: 3432181
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy.
    Hamburg P; Weilburg JB; Cassem NH; Cohen L; Brown S
    Compr Psychiatry; 1986; 27(4):272-5. PubMed ID: 3731763
    [No Abstract]   [Full Text] [Related]  

  • 6. [Successful use of amantadine in treatment of malignant neuroleptic syndrome].
    Blümlein G
    Psychiatr Prax; 1997 Sep; 24(5):257-8. PubMed ID: 9417555
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury.
    Wilkinson R; Meythaler JM; Guin-Renfroe S
    Brain Inj; 1999 Dec; 13(12):1025-31. PubMed ID: 10628507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrapyramidal reactions and neuroleptic malignant syndrome].
    Gómez EA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing treatment of neuroleptic malignant syndrome.
    Susman VL; Addonizio G
    Am J Psychiatry; 1986 Jan; 143(1):120-1. PubMed ID: 3942270
    [No Abstract]   [Full Text] [Related]  

  • 10. Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.
    Kornhuber J; Weller M
    J Neural Transm Gen Sect; 1993; 92(1):57-65. PubMed ID: 8101093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical neuroleptic malignant syndrome with clozapine and subsequent haloperidol treatment.
    Spivak M; Adams B; Crockford D
    Can J Psychiatry; 2003 Feb; 48(1):66. PubMed ID: 12635570
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal-induced neuroleptic malignant syndrome.
    Bower DJ; Chalasani P; Ammons JC
    Am J Psychiatry; 1994 Mar; 151(3):451-2. PubMed ID: 8109662
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug treatment of the neuroleptic malignant syndrome.
    Sakkas P; Davis JM; Janicak PG; Wang ZY
    Psychopharmacol Bull; 1991; 27(3):381-4. PubMed ID: 1685592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome.
    Weller M; Kornhuber J
    Med Hypotheses; 1992 Aug; 38(4):329-33. PubMed ID: 1337136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome.
    Haisma HJ; Constantinou E; Chinyanga HM
    Cent Afr J Med; 1990 May; 36(5):141-3. PubMed ID: 2261628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant neuroleptic syndrome and biperiden].
    Capellà Hereu D; Cabeza Gutés D; Laporte Roselló JR
    Med Clin (Barc); 1985 Nov; 85(17):728-9. PubMed ID: 4087961
    [No Abstract]   [Full Text] [Related]  

  • 17. Pridinolum mesylate and neuroleptic malignant syndrome.
    Giordani L; Amore M; Montanari A; Berlinzani L; Gentili C
    Am J Psychiatry; 1985 Mar; 142(3):389-90. PubMed ID: 3970286
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.
    Ryken TC; Merrell AN
    West J Med; 1989 Sep; 151(3):326-8. PubMed ID: 2588570
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: case report in a multiple trauma patient.
    Hirst R; Galloway GQ; Borzotta AP
    Injury; 1993 Mar; 24(3):193-4. PubMed ID: 8509195
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status.
    Fryml LD; Williams KR; Pelic CG; Fox J; Sahlem G; Robert S; Revuelta GJ; Short EB
    J Psychiatr Pract; 2017 May; 23(3):191-199. PubMed ID: 28492457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.